Brolucizumab for Diabetic Macular Edema
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
KESTREL and KITE: 52-week results from two Phase III pivotal trials of brolucizumab for diabetic macular edema
Am J Ophthalmol 2022 Jan 13;[EPub Ahead of Print], DM Brown, A Emanuelli, F Bandello, JJE Barranco, J Figueira, E Souied, S Wolf, V Gupta, NF Ngah, G Liew, R Tuli, R Tadayoni, D Dhoot, L Wang, E Bouillaud, Y Wang, L Kovacic, N Guerard, JG GarwegFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.